Screening test for antibodies to HIV type 1, groups M and O, and HIV type 2

[Guest guest]

The Food and Drug Administration (FDA) licensed, on September 18, 2009, the

Abbott Prism HIV O Plus assay, a new screening tool designed to detect the

presence of antibodies to the two types of the virus that causes AIDS, HIV 1 and

HIV 2. Both types can be transmitted by sexual contact, through blood, and by

mother to child transmission.

 

The new assay is one of five assays that run on the fully automated Abbott Prism

System.

 

HIV type 1 consists of various subgroups, including group M, the most common

subgroup of the virus in the United States, and group O, found primarily in

Cameroon and other areas of West Africa.

 

HIV type 2 is found mostly in West Africa. Both types have been detected in the

United States and Europe.

 

The Abbott Prism HIV O Plus assay detects antibodies to HIV type 1, groups M and

O, and HIV type 2. It is the second donor screening test licensed for the

detection of antibodies to HIV type 1, group O.

The Abbott Prism HIV O Plus assay is licensed to screen donated blood and blood

specimens from other living donors (e.g., organ or tissue donors) for these

specific types of HIV and subgroups of HIV type 1.

The assay is also licensed to screen specimens from organ donors when specimens

are obtained while the donor's heart is still beating and from cadavers.

Positive results from the screening test require confirmation from supplemental

tests. 

 

The Abbott Prism HIV O Plus assay and the Abbot Prism system are manufactured by

Abbott Laboratories, Abbott Park, Ill. 

Klein

Office of Special Health Issues 

Food and Drug Administration 

Strubl

Division of Antiviral Drug Products 

Food and Drug Administration

U.S. Food & Drug Administration (FDA)

e-mail: <fda@...>